| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |